BP three-lens brief
Evidence-based stock research on BP. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $47.43 — 23% above current (16 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $47.43 — 23% above current (16 analysts).
- Earnings scheduled 2026-08-04.
BP closed at $38.60 (+0.13%) as of 2026-07-10. Market cap: $99.40B. P/E (trailing) 31.1. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $47.43 — 23% above current (16 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.. Last quarter: Revenue $52.26B, net income $3.84B, free cash flow $10.05B. Watching for: 2026-08-04 earnings release (24 days out).
Why three lenses on BP, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BPacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BP" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BP brief"></iframe>